MedPath

Redustim device for reduction of abdominal obesity

Not Applicable
Conditions
local obesity.
Registration Number
IRCT20190210042676N3
Lead Sponsor
Amico Yasna Pars Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

People who suffering from abdominal obesity
Signing the consent form for participation in the study
Women or men between 18 to 60

Exclusion Criteria

Uncontrolled hypertention
Currently pregnant or lactating
Deep vascular tumors
Endocrine disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Abdominal size. Timepoint: Before starting treatment, the second week and the 4th week after treatment. Method of measurement: Centimeter.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath